首页> 美国卫生研究院文献>ISRN Pharmaceutics >Suitability of Biomorphic Silicon Carbide Ceramics as Drug Delivery Systems against Bacterial Biofilms
【2h】

Suitability of Biomorphic Silicon Carbide Ceramics as Drug Delivery Systems against Bacterial Biofilms

机译:生物形态碳化硅陶瓷作为抗细菌生物膜的药物递送系统的适用性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present work is aimed at getting a new insight into biomorphic silicon carbides (bioSiCs) as bone replacement materials. BioSiCs from a variety of precursors were produced, characterized, and loaded with a broad-spectrum antibiotic. The capacity of loaded bioSiCs for preventing and/or treating preformed S. aureus biofilms has been studied. The differences in precursor characteristics are maintained after the ceramic production process. All bioSiCs allow the loading process by capillarity, giving loaded materials with drug release profiles dependent on their microstructure. The amount of antibiotic released in liquid medium during the first six hours depends on bioSiC porosity, but it could exceed the minimum inhibitory concentration of Staphylococcus aureus, for all the materials studied, thus preventing the proliferation of bacteria. Differences in the external surface and the number and size of open external pores of bioSiCs contribute towards the variations in the effect against bacteria when experiments are carried out using solid media. The internal structure and surface properties of all the systems seem to facilitate the therapeutic activity of the antibiotic on the preformed biofilms, reducing the number of viable bacteria present in the biofilm compared to controls.
机译:当前的工作旨在获得对作为骨替代材料的生物形态碳化硅(bioSiCs)的新见解。从各种前体中生产出BioSiC,并对其进行了表征,并装载了广谱抗生素。已经研究了负载的bioSiCs预防和/或处理预先形成的金黄色葡萄球菌生物膜的能力。在陶瓷生产过程之后,可以保持前驱物特性的差异。所有bioSiC均允许通过毛细作用进行加载过程,从而使加载的材料具有取决于其微观结构的药物释放曲线。前六个小时在液体培养基中释放的抗生素量取决于bioSiC的孔隙率,但对于所有研究的材料,它都可能超过金黄色葡萄球菌的最低抑制浓度,从而防止了细菌的繁殖。当使用固体培养基进行实验时,bioSiCs的外表面以及开放的外部孔的数量和大小的差异会导致细菌抵抗效果的变化。所有系统的内部结构和表面性质似乎促进了抗生素对预先形成的生物膜的治疗活性,与对照相比,减少了生物膜中存在的活细菌的数量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号